Manifestações oculares em pacientes pediátricos com leucemia linfoblástica aguda: uma coorte de cinco anos

Detalhes bibliográficos
Autor(a) principal: Silva, Wallace Marcelo Almeida
Data de Publicação: 2019
Tipo de documento: Trabalho de conclusão de curso
Idioma: por
Título da fonte: Repositório Institucional da UFS
Texto Completo: http://ri.ufs.br/jspui/handle/riufs/15778
Resumo: Objective: To characterize ocular manifestations (OM) of pediatric patients treating for acute lymphoblastic leukemia (ALL) and to evaluate whether they are associated with well-described predictive risk factors for relapse, protocol (1999 or 2009), gender and cerebrospinal fluid infiltration. Methods: A prospective cohort study was conducted in children and adolescents with ALL from January 2013 to December 2017. The patients underwent ophthalmologic evaluations before starting treatment (D0), on the eighth day (D8), at the 28th day (D28), and at six months (D6 months). Ocular hypertension (OH) was considered in results above 21 mmHg. Measures of visual acuity < 20/40 were considered visual loss (VL). Results: Fifty-five patients were examined and 18 (32.7%) presented OM, been OH (61.1%), retinal hemorrhage (22.2%) and VL (22.2%) the most frequent finds. A strong association was found between patients with OM and those with a high risk of relapse (p = 0.035, Cramer V = 0.31) and who used the 1999 protocol (p = 0.022, Cramer V = 0.32). The risk of OM in patients from the 1999 protocol was 2.917 (CI = 1.099–7.742), while the risk of relapse it was 0.327 (CI 95% 0.107–0.999). Conclusions: Patients with ALL have a high incidence of OM due to the treatment and the disease itself, and it may even be asymptomatic and evolve with VL. Of these, we can highlight OH as the most prevalent. Patients submitted to the 1999 protocol and at high risk of relapse are more likely to present OM and these variables are strongly associated.
id UFS-2_1eb89b5fc7f31a56e6593cfc57d259c9
oai_identifier_str oai:ufs.br:riufs/15778
network_acronym_str UFS-2
network_name_str Repositório Institucional da UFS
repository_id_str
spelling Silva, Wallace Marcelo AlmeidaCipolotti, Rosana2022-05-26T12:20:51Z2022-05-26T12:20:51Z2019-02-27SILVA,Wallace Marcelo Almeida. Manifestações oculares em pacientes pediátricos com leucemia linfoblástica aguda: uma coorte de cinco anos. 2019. 48 f. Monografia (Graduação em Medicina) - Centro de Ciências Biológicas e da Saúde, Departamento de Medicina, Universidade Federal de Sergipe, Aracaju, 2019.http://ri.ufs.br/jspui/handle/riufs/15778Objective: To characterize ocular manifestations (OM) of pediatric patients treating for acute lymphoblastic leukemia (ALL) and to evaluate whether they are associated with well-described predictive risk factors for relapse, protocol (1999 or 2009), gender and cerebrospinal fluid infiltration. Methods: A prospective cohort study was conducted in children and adolescents with ALL from January 2013 to December 2017. The patients underwent ophthalmologic evaluations before starting treatment (D0), on the eighth day (D8), at the 28th day (D28), and at six months (D6 months). Ocular hypertension (OH) was considered in results above 21 mmHg. Measures of visual acuity < 20/40 were considered visual loss (VL). Results: Fifty-five patients were examined and 18 (32.7%) presented OM, been OH (61.1%), retinal hemorrhage (22.2%) and VL (22.2%) the most frequent finds. A strong association was found between patients with OM and those with a high risk of relapse (p = 0.035, Cramer V = 0.31) and who used the 1999 protocol (p = 0.022, Cramer V = 0.32). The risk of OM in patients from the 1999 protocol was 2.917 (CI = 1.099–7.742), while the risk of relapse it was 0.327 (CI 95% 0.107–0.999). Conclusions: Patients with ALL have a high incidence of OM due to the treatment and the disease itself, and it may even be asymptomatic and evolve with VL. Of these, we can highlight OH as the most prevalent. Patients submitted to the 1999 protocol and at high risk of relapse are more likely to present OM and these variables are strongly associated.Objectivo: Caracterizar as manifestações oculares (OM) de pacientes pediátricos que tratam de linfoblastos agudos leucemia (ALL) e para avaliar se estão associados a factores de risco preditivos bem descritos de recaída, protocolo (1999 ou 2009), género e infiltração do líquido cefalorraquidiano. Métodos: Foi realizado um estudo de coorte prospectivo em crianças e adolescentes com TODOS, de Janeiro de 2013 a Dezembro de 2017. Os pacientes foram submetidos a avaliações oftalmológicas antes de iniciar o tratamento (D0), no oitavo dia (D8), ao 28º dia (D28), e aos seis meses (D6 meses). A hipertensão ocular (OH) foi considerada em resultados acima dos 21 mmHg. As medidas de acuidade visual < 20/40 foram consideradas perda visual (VL). Resultados: Cinquenta e cinco pacientes foram examinados e 18 (32,7%) apresentaram OM, foram OH (61,1%), hemorragia da retina (22,2%) e VL (22,2%) os achados mais frequentes. Foi encontrada uma forte associação entre doentes com OM e aqueles com elevado risco de recaída (p = 0,035, Cramer V = 0,31) e que utilizaram o protocolo de 1999 (p = 0,022, Cramer V = 0,32). O risco de OM nos doentes do protocolo de 1999 era de 2,917 (CI = 1,099-7,742), enquanto que o risco de recaída foi de 0,327 (IC 95% 0,107-0,999). Conclusões: Os doentes com TODOS têm uma elevada incidência de OM devido ao tratamento e à própria doença, e podem até ser assintomáticos e evoluir com a VL. Destes, podemos destacar OH como o mais prevalecente. Pacientes submetidas ao protocolo de 1999 e com elevado risco de recaída são mais susceptíveis de apresentar OM e estas variáveis são fortemente associado.AracajuporLeucemia linfoblástica agudaGlaucomaEsteróidesQuimioterapiaAcute lymphoblastic leukemiaGlaucomaSteroidsChemotherapyCIENCIAS DA SAUDE::MEDICINAManifestações oculares em pacientes pediátricos com leucemia linfoblástica aguda: uma coorte de cinco anosinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/bachelorThesisUniversidade Federal de SergipeDME - Departamento de Medicina – Aracaju - Presencialreponame:Repositório Institucional da UFSinstname:Universidade Federal de Sergipe (UFS)instacron:UFSinfo:eu-repo/semantics/openAccessLICENSElicense.txtlicense.txttext/plain; charset=utf-81475https://ri.ufs.br/jspui/bitstream/riufs/15778/1/license.txt098cbbf65c2c15e1fb2e49c5d306a44cMD51ORIGINALWallace_Marcelo_Almeida_Silva.pdfWallace_Marcelo_Almeida_Silva.pdfapplication/pdf656148https://ri.ufs.br/jspui/bitstream/riufs/15778/2/Wallace_Marcelo_Almeida_Silva.pdf9a7e1edc5e57bef253e2642241164827MD52TEXTWallace_Marcelo_Almeida_Silva.pdf.txtWallace_Marcelo_Almeida_Silva.pdf.txtExtracted texttext/plain104531https://ri.ufs.br/jspui/bitstream/riufs/15778/3/Wallace_Marcelo_Almeida_Silva.pdf.txt9a7f550d17d193435fe2da608745ce0aMD53THUMBNAILWallace_Marcelo_Almeida_Silva.pdf.jpgWallace_Marcelo_Almeida_Silva.pdf.jpgGenerated Thumbnailimage/jpeg1277https://ri.ufs.br/jspui/bitstream/riufs/15778/4/Wallace_Marcelo_Almeida_Silva.pdf.jpgf3a92d60969827afb4f150fc7926fc9eMD54riufs/157782022-05-26 09:20:52.146oai:ufs.br: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Repositório InstitucionalPUBhttps://ri.ufs.br/oai/requestrepositorio@academico.ufs.bropendoar:2022-05-26T12:20:52Repositório Institucional da UFS - Universidade Federal de Sergipe (UFS)false
dc.title.pt_BR.fl_str_mv Manifestações oculares em pacientes pediátricos com leucemia linfoblástica aguda: uma coorte de cinco anos
title Manifestações oculares em pacientes pediátricos com leucemia linfoblástica aguda: uma coorte de cinco anos
spellingShingle Manifestações oculares em pacientes pediátricos com leucemia linfoblástica aguda: uma coorte de cinco anos
Silva, Wallace Marcelo Almeida
Leucemia linfoblástica aguda
Glaucoma
Esteróides
Quimioterapia
Acute lymphoblastic leukemia
Glaucoma
Steroids
Chemotherapy
CIENCIAS DA SAUDE::MEDICINA
title_short Manifestações oculares em pacientes pediátricos com leucemia linfoblástica aguda: uma coorte de cinco anos
title_full Manifestações oculares em pacientes pediátricos com leucemia linfoblástica aguda: uma coorte de cinco anos
title_fullStr Manifestações oculares em pacientes pediátricos com leucemia linfoblástica aguda: uma coorte de cinco anos
title_full_unstemmed Manifestações oculares em pacientes pediátricos com leucemia linfoblástica aguda: uma coorte de cinco anos
title_sort Manifestações oculares em pacientes pediátricos com leucemia linfoblástica aguda: uma coorte de cinco anos
author Silva, Wallace Marcelo Almeida
author_facet Silva, Wallace Marcelo Almeida
author_role author
dc.contributor.author.fl_str_mv Silva, Wallace Marcelo Almeida
dc.contributor.advisor1.fl_str_mv Cipolotti, Rosana
contributor_str_mv Cipolotti, Rosana
dc.subject.por.fl_str_mv Leucemia linfoblástica aguda
Glaucoma
Esteróides
Quimioterapia
topic Leucemia linfoblástica aguda
Glaucoma
Esteróides
Quimioterapia
Acute lymphoblastic leukemia
Glaucoma
Steroids
Chemotherapy
CIENCIAS DA SAUDE::MEDICINA
dc.subject.eng.fl_str_mv Acute lymphoblastic leukemia
Glaucoma
Steroids
Chemotherapy
dc.subject.cnpq.fl_str_mv CIENCIAS DA SAUDE::MEDICINA
description Objective: To characterize ocular manifestations (OM) of pediatric patients treating for acute lymphoblastic leukemia (ALL) and to evaluate whether they are associated with well-described predictive risk factors for relapse, protocol (1999 or 2009), gender and cerebrospinal fluid infiltration. Methods: A prospective cohort study was conducted in children and adolescents with ALL from January 2013 to December 2017. The patients underwent ophthalmologic evaluations before starting treatment (D0), on the eighth day (D8), at the 28th day (D28), and at six months (D6 months). Ocular hypertension (OH) was considered in results above 21 mmHg. Measures of visual acuity < 20/40 were considered visual loss (VL). Results: Fifty-five patients were examined and 18 (32.7%) presented OM, been OH (61.1%), retinal hemorrhage (22.2%) and VL (22.2%) the most frequent finds. A strong association was found between patients with OM and those with a high risk of relapse (p = 0.035, Cramer V = 0.31) and who used the 1999 protocol (p = 0.022, Cramer V = 0.32). The risk of OM in patients from the 1999 protocol was 2.917 (CI = 1.099–7.742), while the risk of relapse it was 0.327 (CI 95% 0.107–0.999). Conclusions: Patients with ALL have a high incidence of OM due to the treatment and the disease itself, and it may even be asymptomatic and evolve with VL. Of these, we can highlight OH as the most prevalent. Patients submitted to the 1999 protocol and at high risk of relapse are more likely to present OM and these variables are strongly associated.
publishDate 2019
dc.date.issued.fl_str_mv 2019-02-27
dc.date.accessioned.fl_str_mv 2022-05-26T12:20:51Z
dc.date.available.fl_str_mv 2022-05-26T12:20:51Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/bachelorThesis
format bachelorThesis
status_str publishedVersion
dc.identifier.citation.fl_str_mv SILVA,Wallace Marcelo Almeida. Manifestações oculares em pacientes pediátricos com leucemia linfoblástica aguda: uma coorte de cinco anos. 2019. 48 f. Monografia (Graduação em Medicina) - Centro de Ciências Biológicas e da Saúde, Departamento de Medicina, Universidade Federal de Sergipe, Aracaju, 2019.
dc.identifier.uri.fl_str_mv http://ri.ufs.br/jspui/handle/riufs/15778
identifier_str_mv SILVA,Wallace Marcelo Almeida. Manifestações oculares em pacientes pediátricos com leucemia linfoblástica aguda: uma coorte de cinco anos. 2019. 48 f. Monografia (Graduação em Medicina) - Centro de Ciências Biológicas e da Saúde, Departamento de Medicina, Universidade Federal de Sergipe, Aracaju, 2019.
url http://ri.ufs.br/jspui/handle/riufs/15778
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.initials.fl_str_mv Universidade Federal de Sergipe
dc.publisher.department.fl_str_mv DME - Departamento de Medicina – Aracaju - Presencial
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFS
instname:Universidade Federal de Sergipe (UFS)
instacron:UFS
instname_str Universidade Federal de Sergipe (UFS)
instacron_str UFS
institution UFS
reponame_str Repositório Institucional da UFS
collection Repositório Institucional da UFS
bitstream.url.fl_str_mv https://ri.ufs.br/jspui/bitstream/riufs/15778/1/license.txt
https://ri.ufs.br/jspui/bitstream/riufs/15778/2/Wallace_Marcelo_Almeida_Silva.pdf
https://ri.ufs.br/jspui/bitstream/riufs/15778/3/Wallace_Marcelo_Almeida_Silva.pdf.txt
https://ri.ufs.br/jspui/bitstream/riufs/15778/4/Wallace_Marcelo_Almeida_Silva.pdf.jpg
bitstream.checksum.fl_str_mv 098cbbf65c2c15e1fb2e49c5d306a44c
9a7e1edc5e57bef253e2642241164827
9a7f550d17d193435fe2da608745ce0a
f3a92d60969827afb4f150fc7926fc9e
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFS - Universidade Federal de Sergipe (UFS)
repository.mail.fl_str_mv repositorio@academico.ufs.br
_version_ 1802110810057605120